ConductScience.org, home

Paper40487574

Challenges in implementing 2021 WHO CNS tumor classification in a resource-limited setting.

Gilani A and 4 others. Neurooncol Pract, 2025. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Challenges in implementing 2021 WHO CNS tumor classification in a resource-limited setting. Papers, record 40487574. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40487574

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Challenges in implementing 2021 WHO CNS tumor classification in a resource-limited setting.
PubMed
Journal
Neurooncol Pract
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.98, provisional
iCite
Revised in PubMed
2025-12-24
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gilani AAhmedhttps://orcid.org/0000-0003-2215-2892
2Altaf AAhmed
3Shakir MMuhammad
4Minhas KKhurram
5Enam SASyed Ather

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128587626Evaluation of a novel antibody to define histone 3.3 G34R mutant brain tumours.Acta Neuropathol Commun2017https://conductscience.org/library/papers/28587626PubMed
236591633Gender disparities in brain tumours: A Pakistan brain tumour epidemiology study analysis.J Pak Med Assoc2022https://conductscience.org/library/papers/36591633PubMed
323161096LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR).Acta Neuropathol2012https://conductscience.org/library/papers/23161096PubMed
438764578Pediatric neuropathology practice in a low- and middle-income country: capacity building through institutional twinning.Front Oncol2024https://conductscience.org/library/papers/38764578PubMed
523575898Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein.Acta Neuropathol2013https://conductscience.org/library/papers/23575898PubMed
629372318cIMPACT-NOW update 1: Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC).Acta Neuropathol2018https://conductscience.org/library/papers/29372318PubMed
733099686Infratentorial C11orf95-fused gliomas share histologic, immunophenotypic, and molecular characteristics of supratentorial RELA-fused ependymoma.Acta Neuropathol2020https://conductscience.org/library/papers/33099686PubMed
831595628Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors.Pediatr Blood Cancer2020https://conductscience.org/library/papers/31595628PubMed
939026106Identification of a putative molecular subtype of adult-type diffuse astrocytoma with recurrent MAPK pathway alterations.Acta Neuropathol2024https://conductscience.org/library/papers/39026106PubMed
1034555175Impact of the methylation classifier and ancillary methods on CNS tumor diagnostics.Neuro Oncol2022https://conductscience.org/library/papers/34555175PubMed
1137574221Announcing the Asian Oceanian Society of Neuropathology guidelines for Adapting Diagnostic Approaches for Practical Taxonomy in Resource-Restrained Regions (AOSNP-ADAPTR).Brain Pathol2024https://conductscience.org/library/papers/37574221PubMed
1236591621The Pakistan Brain Tumour Epidemiology Study.J Pak Med Assoc2022https://conductscience.org/library/papers/36591621PubMed
1328733933Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome.Acta Neuropathol2017https://conductscience.org/library/papers/28733933PubMed
1434725697DNA methylation profiling as a model for discovery and precision diagnostics in neuro-oncology.Neuro Oncol2021https://conductscience.org/library/papers/34725697PubMed
1538312227Differences in methylation profiles between long-term survivors and short-term survivors of IDH-wild-type glioblastoma.Neurooncol Adv2024https://conductscience.org/library/papers/38312227PubMed
1634185076The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.Neuro Oncol2021https://conductscience.org/library/papers/34185076PubMed
1738937309Characteristics of H3K27M-mutant diffuse gliomas with a non-midline location.J Neurooncol2024https://conductscience.org/library/papers/38937309PubMed
1834297434Myxoid glioneuronal tumor, PDGFRA p.K385L-mutant, arising in midbrain tectum with multifocal CSF dissemination.Brain Pathol2022https://conductscience.org/library/papers/34297434PubMed
1937476329Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing.Neurooncol Adv2023https://conductscience.org/library/papers/37476329PubMed
2025427834
ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma.
Acta Neuropathol2015https://conductscience.org/library/papers/25427834PubMed

See all 29 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42877419High-grade gliomas where resources define survival: a systematic review and meta-analysis of outcomes, surgical access, and molecular diagnostic gaps in low- and middle-income countries.Front Oncol2026https://conductscience.org/library/papers/42877419PubMed
42707049Molecular profiling of pediatric medulloblastoma in Kazakhstan: Genomic alterations, subgroup distribution, and survival.Brain Pathol2026https://conductscience.org/library/papers/42707049PubMed
42666069AOSNP-ADAPTR resource level-based recommendations on practical diagnostic strategies for medulloblastomas and other embryonal tumors.Brain Pathol2026https://conductscience.org/library/papers/42666069PubMed
42180673H3K27M-altered diffuse midline glioma: Experience and outcomes from a low-middle income country setting in the contemporary era.Neurooncol Adv2026https://conductscience.org/library/papers/42180673PubMed
41644502Magnetic resonance imaging findings of dysembryoplastic neuroepithelial tumors and low-grade astrocytomas.J Chin Med Assoc2026https://conductscience.org/library/papers/41644502PubMed
40487579The 2021 WHO classification of tumors of the central nervous system: Responding to the challenge in low- and middle-income countries.Neurooncol Pract2025https://conductscience.org/library/papers/40487579PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
IDH13417PubTator's text mininghttps://conductscience.org/library/genes/3417

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40487574

GET https://conductscience.org/api/papers/v1/40487574/references?page=2